Skip to main content

University Of Maryland School Of Medicine Professor Takes Part in White House Meeting to Combat Antibiotic Resistance

June 02, 2015

Anthony D. Harris, MD, MPH

Professor To Play Key Role In White House Forum

University Of Maryland School Of Medicine Professor of Epidemiology & Public Health Anthony D. Harris, MD, MPH, who is also President for the Society for Healthcare Epidemiology of America (SHEA) participated in the Antibiotic Stewardship Forum at the White House on June 2, 2015.

The meeting was part of ongoing efforts by the Obama Administration to tackle antibiotic resistance, with a focus on antibiotic stewardship.

“We are encouraged that the Administration has taken a proactive role in helping find solutions to stem antibiotic resistance, one of the most pressing issues we face in healthcare,” said Dr. Harris.

“Overuse and misuse of antibiotics by healthcare professionals contributes significantly to the problem of antibiotic resistance. A key piece is to launch successful antibiotic stewardship programs, which serve as integrated, coordinated efforts to manage antibiotics across the healthcare spectrum, including hospitals, long-term care institutions, and primary care settings. Leaders of antimicrobial stewardship programs require specific education and training to create programs that are successfully implemented and sustained. Additionally, success lies in creating an overarching culture of understanding where, when and how antibiotics should be used and creating a team available for expert consultation to clarify misunderstandings and direct appropriate use institution-wide.”

“Without real action, antibiotic resistance will continue to threaten patients, increase healthcare costs and eliminate valuable drug interventions setting modern medicine back decades. Healthcare systems must invest in making strong antimicrobial stewardship a way to practice and deliver care based on a team-approach,” said Harris.

“This is an all-hands-on-deck moment. We all need to unite – public organizations, private entities, academic and research institutions, federal, state and local officials, and patient advocates – to address the issue head on, and implement evidence-based interventions such as stewardship in all clinical settings to improve care and preserve the efficacy of trusted antibiotics.”

About the University of Maryland School of Medicine

The University of Maryland School of Medicine was chartered in 1807 and is the first public medical school in the United States and continues today as an innovative leader in accelerating innovation and discovery in medicine. The School of Medicine is the founding school of the University of Maryland and is an integral part of the 11-campus University System of Maryland. Located on the University of Maryland’s Baltimore campus, the School of Medicine works closely with the University of Maryland Medical Center and Medical System to provide a research-intensive, academic and clinically based education. With 43 academic departments, centers and institutes and a faculty of more than 3,000 physicians and research scientists plus more than $400 million in extramural funding, the School is regarded as one of the leading biomedical research institutions in the U.S. with top-tier faculty and programs in cancer, brain science, surgery and transplantation, trauma and emergency medicine, vaccine development and human genomics, among other centers of excellence. The School is not only concerned with the health of the citizens of Maryland and the nation, but also has a global presence, with research and treatment facilities in more than 35 countries around the world.
medschool.umaryland.edu/

Contact

Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559

Contact Media Relations
(410) 706-5260

Related stories